European Archives - Page 548 of 1369 - European Medical Journal

Novel Tool to Predict Kidney Injury from Chemotherapy

A risk prediction model for kidney injury in patients with cancer receiving chemotherapy has been developed.

A doctor conducting hypnotherapy with a patient

Hypnosis: A Magical Tool in Clinical Scenarios – Part 1

This episode explores the use of hypnosis in clinical practice and its impact managing side effects.

Blood Test Predicts Knee Osteoarthritis 8 Years Earlier

A new blood test has successfully predicted risk of knee osteoarthritis eight years before signs of the disease appeared on X-rays.

Connection Between Arthritis and Blood Cancer Mutations

Researches have found a link between rheumatoid arthritis and certain gene mutations found in cancer.

Artificial Intelligence Identifies Small Renal Tumours with Radiologist Precision

A deep learning algorithm based on contrast-enhanced multiphase CT has performed well in identifying small benign renal lesions, according to new research.

Enlarged Lymph Nodes on Mammograms: A New Risk Indicator

Fat-enlarged axillary lymph nodes have been linked to significantly higher risks of type 2 diabetes, cardiovascular disease, and hypertension, according to new research.

FDA nod for Roche and Amgen’s blood testing device

The FDA has granted Breakthrough Device Designation to Roche’s new blood test, developed in collaboration with Amgen, that measures key blood markers of inherited cardiovascular risk.

Higher Olive Oil Consumption Linked to Lower Dementia Mortality

Long-term consumption of olive oil is associated with a significantly lower risk of dementia-related death, regardless of overall diet quality.

Early Mobility in Acute Ischaemic Stroke Linked to Better Outcomes

Early mobility within the first 24 hours of hospital admission can improve functional outcomes for patients with acute ischaemic stroke who receive intravenous thrombolysis, findings show.

Standard Treatment for Acute Myeloid Leukaemia Improves Survival in Elderly

A recent study has found that the standard treatment for acute myeloid leukaemia is both safe and effective for adults aged ≥80 years